{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:30:39Z","timestamp":1790479839738,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.genhosppsych.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:24:41Z","timestamp":1554722681000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Medication prescriptions in 322 motor functional neurological disorder patients in a large UK mental health service: A case control study"],"prefix":"10.1016","volume":"58","author":[{"given":"Nicola","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tavener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp.2010.220640","article-title":"Disability, distress and unemployment in neurology outpatients with symptoms \u2018unexplained by organic disease\u2019","volume":"82","author":"Carson","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0015","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/mds.21687","article-title":"Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology","volume":"22","author":"Anderson","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp-2012-304400","article-title":"Impact of symptoms in patients with functional neurological symptoms on activities of daily living and health related quality of life","volume":"84","author":"Vroegop","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jnnp-2013-305321","article-title":"The prognosis of functional (psychogenic) motor symptoms: a systematic review","volume":"85","author":"Gelauff","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","article-title":"Current concepts in diagnosis and treatment of functional neurological disorders","volume":"75","author":"Espay","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0035","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4088\/JCP.v66n1206","article-title":"Antidepressant treatment outcomes of psychogenic movement disorder","volume":"66","author":"Voon","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000119275","article-title":"Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency","volume":"33","author":"Rampello","year":"1996","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2013.09.012","article-title":"Psychogenic paroxysmal movement disorders \u2013 clinical features and diagnostic clues","volume":"20","author":"Ganos","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.0b013e3181f4d5a9","article-title":"Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures","volume":"75","author":"Lafrance","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/jnp.2010.22.4.401","article-title":"Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and\/or depressive disorders","volume":"22","author":"Pintor","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.genhosppsych.2018.02.001","article-title":"The use of prescription medication in 239 patients with multiple functional somatic syndromes","volume":"51","author":"Agger","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S2215-0366(17)30126-8","article-title":"Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study","volume":"4","author":"Agger","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0070","first-page":"CD010628","article-title":"Pharmacological interventions for somatoform disorders in adults","volume":"11","author":"Kleinst\u00e4uber","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0080","first-page":"CD003460","article-title":"Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome","volume":"8","author":"Ruepert","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.genhosppsych.2008.12.006","article-title":"Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews","volume":"31","author":"Kroenke","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006842-199807000-00019","article-title":"Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis","volume":"60","author":"Fishbain","year":"1998","journal-title":"Psychosom Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0095","first-page":"980","article-title":"Antidepressant therapy for unexplained symptoms and symptom syndromes","volume":"48","author":"O'Malley","year":"1999","journal-title":"J Fam Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ebmh.2.1.13","article-title":"Review: antidepressants reduce pain intensity in psychogenic pain or somatoform pain disorder","volume":"2","author":"Wessely","year":"1999","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0105","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/jnnp-2012-304397","article-title":"Neuropsychological profile of psychogenic jerky movement disorders: importance of evaluating non-credible cognitive performance and psychopathology","volume":"84","author":"Heintz","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0304-3959(98)00074-8","article-title":"A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms","volume":"76","author":"Kouyanou","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2011.05.031","article-title":"Opioid use, misuse, and abuse in patients labeled as fibromyalgia","volume":"124","author":"Fitzcharles","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/apt.14503","article-title":"Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration","volume":"47","author":"Sayuk","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jnnp.60.5.489","article-title":"Prognosis in chronic fatigue syndrome: a prospective study on the natural course","volume":"60","author":"Vercoulen","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.yebeh.2012.10.008","article-title":"Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled study","volume":"25","author":"Gazzola","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.yebeh.2006.11.014","article-title":"Medication use profiles in patients with psychogenic nonepileptic seizures","volume":"10","author":"Hantke","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0140","first-page":"922","article-title":"Chronic functional somatic symptoms: a single syndrome?","volume":"54","author":"olde Hartman","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2013.12.046","article-title":"Physical precipitating factors in functional movement disorders","volume":"338","author":"Pare\u00e9s","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0150","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/brain\/awq068","article-title":"The symptom of functional weakness: a controlled study of 107 patients","volume":"133","author":"Stone","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/art.1790110206","article-title":"Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage","volume":"11","author":"Alexander","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2296-10-68","article-title":"Explanation and relations. How do general practitioners deal with patients with persistent medically unexplained symptoms: a focus group study","volume":"10","author":"Olde Hartman","year":"2009","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.161.10.1289","article-title":"Clinician attributions for symptoms and treatment of gulf war\u2013related health concerns","volume":"161","author":"Richardson","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/21507740.2013.796327","article-title":"Attitudes on mind over matter: physician views on the role of placebo in psychogenic disorders","volume":"4","author":"Rommelfanger","year":"2013","journal-title":"AJOB Neurosci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/mds.22911","article-title":"The treatment of psychogenic movement disorders with suggestion is ethically justified","volume":"25","author":"Shamy","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0180","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.62.8.903","article-title":"Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity","volume":"62","author":"Barsky","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/fampra\/cmq053","article-title":"Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern","volume":"27","author":"McGorm","year":"2010","journal-title":"Fam Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0190","article-title":"Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource","volume":"6","author":"Perera","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0195","series-title":"BNF 74: September 2017","author":"Joint Formulary Committee","year":"2017"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1532-5415.2008.02040.x","article-title":"The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people","volume":"57","author":"Haider","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6904-10-16","article-title":"Increasing polypharmacy - an individual-based study of the Swedish population 2005\u20132008","volume":"10","author":"Hovstadius","year":"2010","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0210","first-page":"1","article-title":"Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case-control study","author":"O'Connell","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0215","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1526-4637.2012.01475.x","article-title":"Burden of illness and treatment patterns for patients with fibromyalgia","volume":"13","author":"Robinson","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yebeh.2015.12.022","article-title":"Number of patient-reported allergies helps distinguish epilepsy from psychogenic nonepileptic seizures","volume":"55","author":"Robbins","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0225","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.psym.2014.05.004","article-title":"A retrospective study of polyallergy as a marker of nonepileptic seizures in the epilepsy monitoring unit","volume":"55","author":"Park","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1176\/appi.neuropsych.16110302","article-title":"Neuropsychiatric associations with gender, illness duration, work disability, and motor subtype in a U.S. functional neurological disorders clinic population","volume":"29","author":"Matin","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0235","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1525-1497.2006.00514.x","article-title":"Managing somatization: medically unexplained should not mean medically ignored","volume":"21","author":"Jackson","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0245","series-title":"Multidisciplinary guideline for medically unexplained symptoms and somatoform disorders","author":"Netherlands Institute of Mental Health and Addiction","year":"2010"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0250","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/jnnp-2013-305716","article-title":"Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study","volume":"85","author":"McCormack","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/practneurol-2015-001241","article-title":"Functional neurological disorders: the neurological assessment as treatment","volume":"16","author":"Stone","year":"2016","journal-title":"Pract Neurol"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0260","doi-asserted-by":"crossref","first-page":"l666","DOI":"10.1136\/bmj.l666","article-title":"Helen Salisbury: the perils of deprescribing","volume":"364","author":"Salisbury","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2296-9-5","article-title":"Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care","volume":"9","author":"de Waal","year":"2008","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0270","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2013-306671","article-title":"Primary and secondary care attendance, anticonvulsant and antidepressant use and psychiatric contact 5\u201310 years after diagnosis in 188 patients with psychogenic non-epileptic seizures","volume":"85","author":"Duncan","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0275","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/mds.23830","article-title":"Psychopathology and psychogenic movement disorders","volume":"26","author":"Kranick","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0280","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0163-8343(98)00044-9","article-title":"Fluvoxamine for somatoform disorders: an open trial","volume":"20","author":"Noyes","year":"1998","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0285","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jns.2015.12.045","article-title":"Medically unexplained visual loss in a specialist clinic: a retrospective case\u2013control comparison","volume":"361","author":"O'Leary","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0290","first-page":"30","article-title":"Antidepressants as analgesics: a review of randomized controlled trials","volume":"26","author":"Lynch","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.1994.tb00308.x","article-title":"Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience","volume":"8","author":"Clouse","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0300","article-title":"Secure attachment and depression predict 6-month outcome in motor functional neurological disorders: a prospective pilot study","author":"Jalilianhasanpour","year":"2018","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fpsyt.2018.00479","article-title":"Processing of emotion in functional neurological disorder","volume":"9","author":"Sojka","year":"2018","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0310","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/brain\/aws129","article-title":"A Bayesian account of \u2018hysteria\u2019","volume":"135","author":"Edwards","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0315","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1528-1167.2008.01862.x","article-title":"Trauma, stress, and preconscious threat processing in patients with psychogenic nonepileptic seizures","volume":"50","author":"Bakvis","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0320","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.24069","article-title":"A \u201ctwist in the tale\u201d: altered perception of ankle position in psychogenic dystonia","volume":"27","author":"Stone","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0325","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","article-title":"Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden","volume":"61","author":"Panchal","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0330","first-page":"7","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0335","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ejp.520","article-title":"Changes in opioid and other analgesic use 1995\u20132010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland","volume":"19","author":"Ruscitto","year":"2015","journal-title":"Eur J Pain"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MLR.0000000000000841","article-title":"The association between local economic conditions and opioid prescriptions among disabled Medicare beneficiaries","volume":"56","author":"Zhou","year":"2018","journal-title":"Med Care"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0350","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpain.2010.11.002","article-title":"Somatization is associated with non-adherence to opioid prescriptions","volume":"12","author":"Trafton","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0360","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0365","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/mds.22220","article-title":"Psychogenic movement disorders in children","volume":"23","author":"Ferrara","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0370","first-page":"31","article-title":"Varying uses of anticonvulsant medications","volume":"5","author":"Cascade","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0375","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/jcp.0b013e318059361a","article-title":"The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence","volume":"27","author":"Mula","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2019.04.004_bb0380","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jnnp.2006.100222","article-title":"Movement disorders in patients taking anticonvulsants","volume":"78","author":"Zadikoff","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834319300830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834319300830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:51:09Z","timestamp":1759013469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834319300830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":76,"alternative-id":["S0163834319300830"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.04.004","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication prescriptions in 322 motor functional neurological disorder patients in a large UK mental health service: A case control study","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}